Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,022 | 0,034 | 04.09. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
28.08. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.08.2025 | 508 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 28.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.08.2025.ISIN NameAU000000DHG9 DOMAIN... ► Artikel lesen | |
15.08. | Stagezero Life Sciences Ltd (2): Stagezero Life lists on NEX, remains suspended | 3 | Stockwatch | ||
14.08. | StageZero Life Sciences Ltd.: StageZero Announces Listing on the NEX Exchange | 1 | TheNewswire | ||
14.08. | Stagezero Life Sciences Ltd (2): Stagezero Life Sciences downgraded to NEX | 1 | Stockwatch | ||
STAGEZERO LIFE SCIENCES Aktie jetzt für 0€ handeln | |||||
25.07. | Stagezero Life Sciences Ltd (2): Stagezero to delist from TSX, applies for NEX listing | 2 | Stockwatch | ||
25.07. | StageZero Life Sciences Ltd.: StageZero Announces Delisting from the TSX and a Concomitant Application for Listing on the NEX Exchange | 1 | TheNewswire | ||
14.05. | Stagezero Life Sciences Ltd (2): Stagezero, ElevationMD use Aristotle to detect cancer | 1 | Stockwatch | ||
13.05. | StageZero Life Sciences Ltd.: StageZero Life Sciences and ElevationMD Introduce Aristotle and AVRT for the Early Detection of Cancer | 3 | TheNewswire | ||
07.05. | StageZero Life Sciences Ltd.: StageZero Announces Partial Revocation of Cease Trade Order and Proposed Financing | 4 | TheNewswire |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
CARL ZEISS MEDITEC | 41,780 | -1,69 % | Wachstumsschmerz, Durchbruch und Entlassungen - Carl Zeiss Meditec, MiMedia Holdings, Nio | Die deutsche Automobilindustrie ist seit drei Jahren in einer tiefen Krise. Überkapazitäten belasten die Konzerne und die Verkaufszahlen im wichtigsten Absatzmarkt China brachen um bis zu 50 % im Vergleich... ► Artikel lesen | |
INTUITIVE SURGICAL | 389,60 | +2,95 % | Intuitive Surgical-Aktie: Der Highflyer stürzt zu Boden | Jahrelang gehörte die Intuitive Surgical-Aktie zu den Tech-Highflyern an der Börse und stellte die Performance des Nasdaq 100 kontinuierlich in den Schatten. Doch der Highflyer stürzt seit geraumer... ► Artikel lesen | |
BOSTON SCIENTIFIC | 91,80 | -0,65 % | The top Boston Scientific stories of 2025 so far | ||
PLUS THERAPEUTICS | 0,452 | 0,00 % | Plus Therapeutics stock rating upgraded to Buy by D. Boral Capital | ||
MOUNTAIN VALLEY MD | 0,004 | +200,00 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
EMPOWER CLINICS | - | - | Empower Clinics Inc. - REVOKED, Commission order revoking Exchange Act registration [Section 12(j)] | ||
LIFEWARD | 0,552 | -2,94 % | Lifeward Ltd.: Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership | MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
SENSEONICS | 0,400 | +3,79 % | Senseonics Holdings, Inc.: Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365 | CGM commercial operations to transition from Ascensia Diabetes Care to Senseonics Brian Hansen to be appointed Chief Commercial Officer Non-dilutive debt facility expanded up to $100 million with... ► Artikel lesen | |
EKSO BIONICS | 4,040 | 0,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
IMUNON | 5,040 | +2,34 % | Imunon, Inc.: IMUNON Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement | LAWRENCEVILLE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the Company... ► Artikel lesen | |
BIOCEPT | 7,200 | 0,00 % | GlaxoSmithKline Bioc: Gewinn im zweiten Quartal bei 5,9 Mio. EGP | ||
ROCKWELL MEDICAL | 1,464 | -1,68 % | ROCKWELL MEDICAL, INC. - S-8, Securities to be offered to employees in employee benefit plans | ||
AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
MEMPHASYS | 0,002 | 0,00 % | XFRA IG7: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
VIRIDIAN THERAPEUTICS | 15,875 | -5,03 % | These Analysts Revise Their Forecasts On Viridian Therapeutics Following Q2 Results |